Eton Pharmaceuticals (ETON) Change in Accured Expenses (2018 - 2025)
Eton Pharmaceuticals' Change in Accured Expenses history spans 7 years, with the latest figure at $426000.0 for Q4 2025.
- On a quarterly basis, Change in Accured Expenses fell 79.15% to $426000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 31.87% decrease, with the full-year FY2025 number at $1.0 million, down 31.87% from a year prior.
- Change in Accured Expenses hit $426000.0 in Q4 2025 for Eton Pharmaceuticals, down from $1.8 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for ETON hit a ceiling of $2.0 million in Q4 2024 and a floor of -$1.6 million in Q1 2024.
- Historically, Change in Accured Expenses has averaged $326850.0 across 5 years, with a median of $397000.0 in 2021.
- Biggest five-year swings in Change in Accured Expenses: skyrocketed 4230.0% in 2023 and later crashed 232.28% in 2024.
- Tracing ETON's Change in Accured Expenses over 5 years: stood at $120000.0 in 2021, then plummeted by 153.33% to -$64000.0 in 2022, then soared by 2246.88% to $1.4 million in 2023, then surged by 48.69% to $2.0 million in 2024, then plummeted by 79.15% to $426000.0 in 2025.
- Business Quant data shows Change in Accured Expenses for ETON at $426000.0 in Q4 2025, $1.8 million in Q3 2025, and $172000.0 in Q2 2025.